Nonalcoholic steatohepatitis: risk factors and diagnosis

被引:28
作者
Adams, Leon A. [2 ]
Feldstein, Ariel E. [1 ]
机构
[1] Cleveland Clin, Dept Cell Biol & Pediat Gastroenterol, Cleveland, OH 44195 USA
[2] Univ Western Australia, Sch Med & Pharmacol, Sir Charles Gairdner Hosp Unit, Nedlands, WA 6009, Australia
关键词
cirrhosis; cytokeratin-18; diabetes; insulin resistance; liver biopsy; nonalcoholic steatohepatitis; obesity; FATTY LIVER-DISEASE; CLINICAL SCORING SYSTEM; TERM-FOLLOW-UP; INSULIN-RESISTANCE; HEPATOCELLULAR-CARCINOMA; LIPID-PEROXIDATION; OBESE-PATIENTS; NONINVASIVE BIOMARKER; HISTOLOGIC SPECTRUM; PLASMA ADIPONECTIN;
D O I
10.1586/EGH.10.56
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic steatohepatitis (NASH) represents the progressive form of nonalcoholic fatty liver disease with greater potential to lead to liver-related morbidity and mortality. Diagnosing NASH mandates more intensive clinical management and consideration for clinical trials. Currently, the diagnosis of NASH requires a liver biopsy, which is invasive, with drawbacks in sampling and interpretation error. Clinical risk factors for NASH include diabetes and the metabolic syndrome; however, these are not sufficiently predictive of the condition by themselves. Routine liver aminotransaminase levels are not reliable; however, novel plasma hepatocyte apoptosis markers, either alone or in combination with clinical risk factors, are potential noninvasive diagnostic tools for the future.
引用
收藏
页码:623 / 635
页数:13
相关论文
共 123 条
[21]   Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: Implications for treatment [J].
Carter-Kent, Christine ;
Zein, Nizar N. ;
Feldstein, Ariel E. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (04) :1036-1042
[22]   Nonalcoholic Steatohepatitis in Children: A Multicenter Clinicopathological Study [J].
Carter-Kent, Christine ;
Yerian, Lisa M. ;
Brunt, Elizabeth M. ;
Angulo, Paul ;
Kohli, Rohit ;
Ling, Simon C. ;
Xanthakos, Stavra A. ;
Whitington, Peter F. ;
Charatcharoenwitthaya, Phunchai ;
Yap, Jason ;
Lopez, Rocio ;
McCullough, Arthur J. ;
Feldstein, Ariel E. .
HEPATOLOGY, 2009, 50 (04) :1113-1120
[23]   Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis [J].
Chalasani, N ;
Deeg, MA ;
Crabb, DW .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (08) :1497-1502
[24]   Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease [J].
Charlton, Michael ;
Angulo, Paul ;
Chalasani, Naga ;
Merriman, Ralph ;
Viker, Kimberly ;
Charatcharoenwitthaya, Phunchai ;
Sanderson, Schuyler ;
Gawrieh, Samer ;
Krishnan, Anuradha ;
Lindor, Keith .
HEPATOLOGY, 2008, 47 (02) :484-492
[25]   The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome [J].
Cheung, Onpan ;
Kapoor, Ashwani ;
Puri, Puneet ;
Sistrun, Sakita ;
Luketic, Velimir A. ;
Sargeant, Carol C. ;
Contos, Melissa J. ;
Shiffman, Mitchell L. ;
Stravitz, Richard T. ;
Sterling, Richard K. ;
Sanyal, Arun J. .
HEPATOLOGY, 2007, 46 (04) :1091-1100
[26]   Long term prognosis of fatty liver: risk of chronic liver disease and death [J].
Dam-Larsen, S ;
Franzmann, M ;
Andersen, IB ;
Christoffersen, P ;
Jensen, LB ;
Sorensen, TIA ;
Becker, U ;
Bendtsen, F .
GUT, 2004, 53 (05) :750-755
[27]   Nonobese Population in a Developing Country Has a High Prevalence of Nonalcoholic Fatty Liver and Significant Liver Disease [J].
Das, Kausik ;
Das, Kshaunish ;
Mukherjee, Partha S. ;
Ghosh, Ali ;
Ghosh, Sumantra ;
Mridha, Asit R. ;
Dhibar, Tapan ;
Bhattacharya, Bhaskar ;
Bhattacharya, Dilip ;
Manna, Byomkesh ;
Dhali, Gopal K. ;
Santra, Amal ;
Chowdhury, Abhijit .
HEPATOLOGY, 2010, 51 (05) :1593-1602
[28]   Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study [J].
de Ledinghen, Victor ;
Ratziu, Vlad ;
Causse, Xavier ;
Le Bail, Brigitte ;
Capron, Dominique ;
Renou, Christophe ;
Pilette, Christophe ;
Oules, Valerie ;
Gelsi, Eve ;
Oberti, Frederic ;
Vallet-Pichard, Anais ;
Le Provost, Nicolas ;
Cadranel, Jean-Francois .
JOURNAL OF HEPATOLOGY, 2006, 45 (04) :592-599
[29]   Cause-specific mortality in type 2 diabetes - The Verona Diabetes Study [J].
de Marco, R ;
Locatelli, F ;
Zoppini, G ;
Verlato, G ;
Bonora, E ;
Muggeo, M .
DIABETES CARE, 1999, 22 (05) :756-761
[30]   Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients [J].
Diab, Dima L. ;
Yerian, Lisa ;
Schauer, Philip ;
Kashyap, Sangeeta R. ;
Lopez, Rocio ;
Hazen, Stanley L. ;
Feldstein, Ariel E. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (11) :1249-1254